IP Library Granted Patent US 12,037,475
Granted Patent B2
US 12,037,475 · App. 17/197,766 · Granted Jul 16, 2024

Compositions comprising Z-1, 1, 1,4,4,4-hexafluoro-2-butene and uses thereof

Inventors: Mario Joseph Nappa (Leesburg, FL); Xuehui Sun (Kennett Square, PA); Ivan Sergeyevich Baldychev (Wilmington, DE); Sheng Peng (Hockessin, DE); Konstantinos Kontomaris (Wilmington, DE); Barbara Haviland Minor (The Villages, FL); Joseph Anthony Creazzo (Wilmington, DE)
Assignee: THE CHEMOURS COMPANY FC, LLC
C08J9/143C09K3/30C09K5/045C08J2203/142C08J2203/162C08J2203/182C08J2203/202C09K2205/12C09K2205/122C09K2205/126C09K2205/22C09K2205/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,037,475
App. No.
17/197,766
Granted
Jul 16, 2024
Kind
B2
Abstract

The present disclosure relates to compositions comprising Z-1,1,1,4,4,4-hexafluoro-2-butene and additional compounds that may be useful as refrigerants, heat transfer compositions, aerosol propellants, foaming agents, blowing agents, solvents, cleaning agents, carrier fluids, displacement drying agents, buffing abrasion agents, polymerization media, expansion agents for polyolefins and polyurethane, gaseous dielectrics, power cycle working fluids, extinguishing agents, and fire suppression agents in liquid or vapor form.

Claims (17)

1. A composition comprising Z-HFO-1336mzz and at least one additional compound selected from the group consisting of HCFO-1223, CFC-113a, HCFC-123a, and chlorobutane wherein the composition contains less than about 1 weight percent of said at least one additional compound, based on the total weight of the composition.

2. The composition of claim 1 further comprising at least one tracer compound selected from the group consisting of HFC-356, HCFC-123, HCFC-133a, HFC-143a, HCFO-1122, HCFO-1122a, CFO-1316, HCFO-1335, HFO-1345, and HCFO-1326.

3. The composition of claim 1 , wherein the composition is comprises Z-HFO-1336mzz, CFC-113a, and HFC-365.

4. The composition of claim 1 further comprising from about 1 ppm to about 1000 ppm of at least one tracer compound.

5. The composition of claim 2 wherein HFO-356 is HFO-356mff.

6. The composition of claim 2 wherein CFO-1316 is E-HFO-1316mxx, Z-HFO-1316mxx, or combinations thereof.

7. The composition of claim 2 wherein HCFO-1335 is E-HCFO-1335mzz, Z-HFO-1335mzz, E-HCFO-1335mzx, Z-HFO-1335mzx, or combinations thereof.

8. The composition of claim 2 wherein HFO-1345 is E-HFO-1345mzz, Z-HFO-1345mzz, HFO-1345cm, or combinations thereof.

9. The composition of claim 2 wherein HCFO-1326 is E-HFO-1326mxz, Z-HFO-1326mxz, or combinations thereof.

10. A method for producing cooling comprising evaporating a composition of claim 1 in the vicinity of a body to be cooled, and thereafter condensing said composition.

11. A method for producing heat comprising condensing a composition of claim 1 in the vicinity of a body to be heated, and thereafter evaporating said compositions.

12. A method of forming a foam comprising: (a) adding to a foamable composition a composition of claim 1 ; and (b) processing the foamable composition under conditions effective to form a foam.

13. A process for producing an aerosol product comprising the step of adding a composition of claim 1 to a formulation, including active ingredients in an aerosol container, wherein said composition functions as a propellant.

14. A method for detecting a leak from a container comprising sampling the air in the vicinity of the container and detecting at least one additional compound or at least one tracer compound with means for detecting the leak, wherein the composition of claim 1 is contained inside the container.

15. The process of claim 13 wherein the aerosol product is chosen from an industrial aerosol, consumer aerosol, and medicinal aerosol material.

16. The process of claim 15 wherein the aerosol product is a consumer aerosol, chosen from personal care aerosol products, household aerosol products, and automotive aerosol products.

17. The process of claim 15 wherein the medicinal aerosol material is an anti-asthma or anti-halitosis medication for delivery to accessible mucous membranes or intra-nasally.

Assignments (1)
SECURITY INTEREST Recorded Mar 2, 2022
From: THE CHEMOURS COMPANY FC, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 059552/0001 →
Continuity (4)
Continuation 15546000
Provisional Application 62113246 · Feb 6, 2015
Provisional Application 62153583 · Apr 28, 2015
Related Publication 20210221972A1 · Jul 22, 2021